Liu T, Tan J, Wu M, Fan W, Wei J, Zhu B, et al. High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocel- lular carcinoma (HCC) activity by activating CD39+ CD8+ T cells. Gut.